subscribeSubscribe
Enforcement Report - Week of November 8, 2023

Enforcement Report - Week of November 8, 2023
FDA
08 Nov 2023
Share Share
Attralus Receives FDA and EMA Orphan Designation for AT-01

Attralus Receives FDA and EMA Orphan Designation for AT-01
GLOBENEWSWIRE
19 Dec 2022
Share Share
Attralus Announces New Clinical Data in ATTR CM and AL With AT-01

Attralus Announces New Clinical Data in ATTR CM and AL With AT-01
GLOBENEWSWIRE
12 Sep 2022
Share Share
Novo Integrated Sciences Granted NPN for IoNovo Iodine Branded Product

Novo Integrated Sciences Granted NPN for IoNovo Iodine Branded Product
BUSINESSWIRE
23 Dec 2021
Share Share
Novo Integrated Sciences Granted NPN for IoNovo Iodine Branded Product

Novo Integrated Sciences Granted NPN for IoNovo Iodine Branded Product
BUSINESSWIRE
23 Dec 2021
Share Share
Medolife Announces Successful Stability Results on Escozine Conjugated

Medolife Announces Successful Stability Results on Escozine Conjugated
GLOBENEWSWIRE
01 Jul 2021
Share Share
Actinium Pharmaceuticals Announces Phase 3 SIERRA Trial Dosimetry Results

Actinium Pharmaceuticals Announces Phase 3 SIERRA Trial Dosimetry Results
PR NEWSWIRE
09 Dec 2019
Share Share
Cancer drug plant likely source of radio isotope detected across Europe

Cancer drug plant likely source of radio isotope detected across Europe
G MacDonald IN PHARMATECHNOLOGIST
23 Feb 2017
Share Share
Vitalah® Announces Three Changes to Adult Oxylent® Formula

Vitalah® Announces Three Changes to Adult Oxylent® Formula
PR NEWSWIRE
03 Nov 2016
Share Share
Health Canada Approves BioPharmX Corporation Study of Violet® Iodine

Health Canada Approves BioPharmX Corporation Study of Violet® Iodine
PR NEWSWIRE
04 Apr 2016
Share Share